First Time Loading...

Ergo Science Corp
OTC:ERGN

Watchlist Manager
Ergo Science Corp Logo
Ergo Science Corp
OTC:ERGN
Watchlist
Price: 10 800 USD
Updated: May 7, 2024

Net Margin
Ergo Science Corp

-16.8%
Current
-8%
Average
2.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-16.8%
=
Net Income
-4.3m
/
Revenue
25.6m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
US
Ergo Science Corp
OTC:ERGN
55.2B USD
-17%
CA
Advance Lithium Corp
XTSX:AALI
526.2B CAD N/A
US
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
332.4B USD N/A
US
Gould Investors LP
OTC:GDVTZ
304.4B USD N/A
US
Carson Energy Development Corp
OTC:CDVM
270.6B USD
-374%
NL
Nepi Rockcastle NV
JSE:NRP
75.9B Zac
62%
US
Liberty Bancshares Inc
OTC:LBSI
55.5B USD N/A
US
HK Graphene Technology Corp
OTC:HKGT
53.9B USD N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
710.7T IDR
39%
US
Myson Group Inc
OTC:MYSN
38.4B USD N/A
US
Coupang Inc
F:788
34.5B EUR
6%
Ergo Science Corp
OTC:ERGN
Country US
Market Cap 55.2B USD
Net Margin
-17%
A
Advance Lithium Corp
XTSX:AALI
Country CA
Market Cap 526.2B CAD
Net Margin N/A
V
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
Country US
Market Cap 332.4B USD
Net Margin N/A
G
Gould Investors LP
OTC:GDVTZ
Country US
Market Cap 304.4B USD
Net Margin N/A
C
Carson Energy Development Corp
OTC:CDVM
Country US
Market Cap 270.6B USD
Net Margin
-374%
N
Nepi Rockcastle NV
JSE:NRP
Country NL
Market Cap 75.9B Zac
Net Margin
62%
Liberty Bancshares Inc
OTC:LBSI
Country US
Market Cap 55.5B USD
Net Margin N/A
H
HK Graphene Technology Corp
OTC:HKGT
Country US
Market Cap 53.9B USD
Net Margin N/A
Amman Mineral Internasional Tbk PT
IDX:AMMN
Country ID
Market Cap 710.7T IDR
Net Margin
39%
M
Myson Group Inc
OTC:MYSN
Country US
Market Cap 38.4B USD
Net Margin N/A
Coupang Inc
F:788
Country US
Market Cap 34.5B EUR
Net Margin
6%

Profitability Report

View the profitability report to see the full profitability analysis for Ergo Science Corp.

Full Profitability Report

See Also

Summary
ERGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ERGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ERGN stock valuation using valuation multiples.
Wall Street Estimates
ERGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ERGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-16.8%
=
Net Income
-4.3m
/
Revenue
25.6m
What is the Net Margin of Ergo Science Corp?

Based on Ergo Science Corp's most recent financial statements, the company has Net Margin of -16.8%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.